By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



The Warehouse at Camden Yards
323 West Camden Street, Suite 675
Baltimore  Maryland  21201  U.S.A.
Phone: 410-659-7330 Fax: 410-625-2323



Company News
Lesaffre Invests In Intralytix, A U.S. Biotechnology Company 7/25/2017 6:35:36 AM
Intralytix Receives FDA Regulatory Clearance For Phage-Based Shigella Technology 4/7/2017 6:28:40 AM
Intralytix And BioPhage Therapeutics Partner To Develop Topical Bacteriophage Treatments Of Human Wounds Infected With S. Aureus 4/5/2017 6:35:34 AM
Ferring Pharma Partners With Intralytix To Develop Bacteriophage Treatments For Conditions Associated With The Microbiome And Drug-Resistant Bacteria 1/9/2017 10:51:00 AM
Intralytix And Ferring Pharmaceuticals Collaborate In Novel Bacteriophage-Based IBD Drug Development Project 7/14/2015 9:32:43 AM
Intralytix, Inc. Wins Regulatory Approval for Phage-Based Food Safety Product Effective Against Salmonella 2/28/2013 10:00:37 AM
Intralytix Signs Multiple Project Collaboration Agreement With Procter & Gamble (PG) 9/22/2011 9:25:43 AM
Intralytix Wins FDA Regulatory Clearance for Phage-Based E. coli Technology 3/16/2011 11:14:16 AM
Intralytix Wins US Army Contract to Develop a Phage-Based Probiotic to Manage Shigella Infections 10/9/2009 7:56:45 AM
Intralytix Awarded Patent by USPTO for Bacteriophage Treatment of Colonization by Pathogenic Bacteria, Including MRSA 12/9/2008 2:05:09 PM